+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Anaplastic Thyroid Cancer Drugs Market 2024-2028 - Product Thumbnail Image

Anaplastic Thyroid Cancer Drugs Market 2024-2028

  • Report
  • December 2023
  • 151 Pages
  • Global
From
Non-small Cell Lung Cancer Drugs Market 2023-2027 - Product Thumbnail Image

Non-small Cell Lung Cancer Drugs Market 2023-2027

  • Report
  • May 2023
  • 167 Pages
  • Global
From
HDAC Inhibitors Market 2023-2027 - Product Thumbnail Image

HDAC Inhibitors Market 2023-2027

  • Report
  • January 2023
  • 157 Pages
  • Global
From
Mycosis Fungoides Therapeutics Market 2021-2025 - Product Thumbnail Image

Mycosis Fungoides Therapeutics Market 2021-2025

  • Report
  • February 2021
  • 120 Pages
  • Global
From
Glioblastoma Multiforme Treatment Market 2024-2028 - Product Thumbnail Image

Glioblastoma Multiforme Treatment Market 2024-2028

  • Report
  • October 2024
  • 137 Pages
  • Global
From
Sarcoma Therapeutics Market 2024-2028 - Product Thumbnail Image

Sarcoma Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 143 Pages
  • Global
From
Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Breast Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 450 Pages
  • Global
From
Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Epithelial Ovarian Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Epithelial Ovarian Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Checkpoint Kinase 2 (Chk2) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Checkpoint Kinase 2 (Chk2) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Casein Kinase 2 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Casein Kinase 2 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Checkpoint Kinase 1 (Chk1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Checkpoint Kinase 1 (Chk1) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cyclin-Dependent Kinase 1 (CDK1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclin-Dependent Kinase 1 (CDK1) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Superoxide Dismutase (SOD) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Superoxide Dismutase (SOD) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mayus Kinase 3 (JAK3) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Mayus Kinase 3 (JAK3) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more